ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,549.34
(
-0.39%
)
US Tech 100
15,432.00
(
0.19%
)
Dow Jones
36,054.43
(
-0.19%
)
Brent Oil
74.995
(
0.87%
)
Bitcoin
43,539.33
(
-0.51%
)
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Oragenics Inc (OGEN)

  7. Oragenics Inc (OGEN) News

OGEN Oragenics Inc

3.74
0.00 (0.0%)
Pre Market
Last Updated: 04:11:01
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Oragenics Inc OGEN AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.00 0.0% 3.74 04:11:01
Open Price Low Price High Price Close Price Prev Close
3.74
more quote information »

Recent News

Date Time Source Heading
12/01/202317:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/30/202317:50EDGAR2Form 144 - Report of proposed sale of securities
11/20/202315:45EDGAR2Form 8-K - Current report
11/16/202314:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/02/202307:00EDGAR2Form 8-K - Current report
11/02/202307:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/02/202307:00BWOragenics Issues Update to Shareholders
10/30/202316:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/30/202316:00EDGAR2Form DEF 14A - Other definitive proxy statements
10/18/202308:30BWOragenics Announces Appointment of Bruce Cassidy and John..
10/06/202316:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/06/202316:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/06/202316:28EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/06/202316:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/05/202317:29EDGAR2Form 8-K - Current report
10/05/202306:30EDGAR2Form 8-K - Current report
10/05/202306:30BWOragenics to Acquire Odyssey Health’s Neurological Drug..
9/29/202316:00EDGAR2Form 8-K - Current report
9/29/202316:00BWOragenics Enters into Agreement with Lantern Bioworks for..
9/15/202316:00EDGAR2Form 8-K - Current report
8/18/202316:15EDGAR2Form 8-K - Current report
8/11/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:30EDGAR2Form 8-K - Current report
8/07/202308:30BWOragenics, Inc. Announces Private Placement
8/07/202308:09EDGAR2Form 8-K - Current report
6/05/202316:18BWOragenics Project to Develop a Variant-Agnostic Protein..
3/29/202311:45BWOragenics to Participate in the World Vaccine Congress..
3/14/202308:30BWOragenics Announces Positive Results in Several Lantibiotics..
3/08/202309:09BWOragenics Appoints Janet Huffman as Chief Financial Officer..
3/01/202307:30BWOragenics Enters into an Exclusive Global License Agreement..
2/03/202307:30BWOragenics, Inc. Regains Compliance with NYSE American
12/23/202216:05BWOragenics, Inc. Discloses One-for-Sixty Reverse Stock Split
12/22/202207:30BWOragenics Reports Favorable Toxicology Results for its..
12/20/202216:36BWOragenics, Inc. Receives NYSE American Notice
12/19/202216:34BWOragenics, Inc. Announces New Chair

Your Recent History

AMEX
OGEN
Oragenics
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com